Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) ...

Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

St. Joseph's Hospital was identified as one of the nation's 50 Top Cardiovascular Hospitals®, according to an independent ...

Doctors have found that Covid-19's inflammation can cause long-term cardiovascular issues, such as accelerated plaque buildup ...

Isaac told me afterwards that I started having a seizure. I’d never had one before. I had no idea what was happening to me.” ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European ...

Testosterone worsens the damage caused by a heart attack by increasing the number of white blood cells released from the bone ...

Plaques grew more rapidly in COVID patients, increasing by 0.9% a year compared with 0.6% a year among the uninfected, ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.